Ginseng and obesity : observations and understanding in cultured cells, animals and humans

Copyright © 2016 Elsevier Inc. All rights reserved..

Ginseng, a traditional medical herb, has been reported having beneficial effects in fatigue, heart diseases, diabetes, immune function and erectile dysfunction. In recent years, increasing investigations have been conducted on ginseng in preventing and treating of obesity, one of the major worldwide escalating public health concerns. However, the effect and the relevant mechanisms behind how ginseng works as an antiobesity treatment are still controversial. In this review, we briefly discussed the chemical structures, metabolism and pharmacokinetics of ginseng and its major bioactive components ginsenosides. The major focus is on the antiobesity effects and the physiological, cellular and molecular mechanisms of ginseng and its ginsenosides in cultured cells, animal models and humans. We particularly compared the ginsenosides profiles, the antiobesity effects and the mechanisms between Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius), the two major ginseng species having opposite medical effects in traditional Chinese medicine. Our unpublished data on the ginseng antiobesity in cultured cells and mice were also included. We further addressed the current problems and future directions of the ginseng antiobesity research.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:44

Enthalten in:

The Journal of nutritional biochemistry - 44(2017) vom: 21. Juni, Seite 1-10

Sprache:

Englisch

Beteiligte Personen:

Zhang, Longyun [VerfasserIn]
Virgous, Carlos [VerfasserIn]
Si, Hongwei [VerfasserIn]

Links:

Volltext

Themen:

Adipocytes
Animals
Anti-Obesity Agents
Antiobesity effects
Ginseng
Ginsenosides
Humans
Journal Article
Mechanisms
Plant Extracts
Research Support, U.S. Gov't, Non-P.H.S.
Review

Anmerkungen:

Date Completed 08.01.2018

Date Revised 09.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jnutbio.2016.11.010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM266932983